EUVIMEDOpdag EUVIMED
Crossref

Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221‐3p/222‐3p axis in glioblastoma

Nargis Malik, Archismita Kundu, Yakhlesh Gupta, Khushboo Irshad, Manvi Arora, Sanjeev Goswami, Swati Mahajan, Chitra Sarkar, Vaishali Suri, Ashish Suri, Parthaprasad Chattopadhyay, Subrata Sinha and 1 more

Molecular Carcinogenesis · 2023

DOI: 10.1002/mc.23617 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2023. Written by Nargis Malik and 12 co-authors. Institution: Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. Major MEDLINE topics: Glioblastoma, Glioma, Brain Neoplasms, MicroRNAs. Cited 5 times so far (Crossref); 64 references. Funded by: Science and Engineering Research Board, Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The atypical cadherin FAT1 function either as a pro or antitumorigenic in tumors of different tissue origins. Our group previously demonstrated the protumorigenic nature of FAT1 signaling in glioblastoma (GBM). In this study, we investigated how FAT1 influences the expression of clustered oncomiRs (miR‐221‐3p/miR‐222‐3p) and their downstream effects in GBM. Through several experiments involving the measurement of specific gene/microRNA expression, gene knockdowns, protein and cellular assays, we have demonstrated a novel oncogenic signaling pathway mediated by FAT1 in glioma. These results have been verified using antimiRs and miR‐mimic assays. Initially, in glioma‐derived cell lines (U87MG and LN229), we observed FAT1 as a novel up‐regulator of the transcription factor NFκB‐RelA. RelA then promotes the expression of the clustered‐oncomiRs, miR‐221‐3p/miR‐222‐3p, which in turn suppresses the expression of the tumor suppressor gene (TSG), PDCD10 (Programmed cell death protein10). The suppression of PDCD10 , and other known TSG targets ( PTEN/PUMA ), by miR‐221‐3p/miR‐222‐3p, leads to increased clonogenicity, migration, and invasion of glioma cells. Consistent with our in‐vitro findings, we observed a positive expression correlation of FAT1 and miR‐221‐3p, and an inverse correlation of FAT1 and the miR‐targets ( PDCD10/PTEN/PUMA ), in GBM tissue‐samples. These findings were also supported by publicly available GBM databases (The Cancer Genome Atlas [TCGA] and The Repository of Molecular Brain Neoplasia Data [Rembrandt]). Patients with tumors displaying high levels of FAT1 and miR‐221‐3p expression (50% and 65% respectively) experienced shorter overall survival. Similar results were observed in the TCGA‐GBM database. Thus, our findings show a novel FAT1/RelA/miR‐221/miR‐222 oncogenic‐effector pathway that downregulates the TSG, PDCD10 , in GBM, which could be targeted therapeutically in a specific manner.

Subjects

MeSH terms (MEDLINE)

GlioblastomaGliomaBrain NeoplasmsMicroRNAsHumansCadherinsApoptosis Regulatory ProteinsCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationCell MovementMembrane ProteinsProto-Oncogene Proteins

Author keywords

FAT1PDCD10glioblastomamiR221-3p/miR222-3pmicroRNAmigration/invasiononcogene

Substances

CadherinsApoptosis Regulatory ProteinsMicroRNAsMembrane ProteinsProto-Oncogene ProteinsFAT1 protein, humanPDCD10 protein, humanMIR221, human

Authors and institutions

  • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
  • Neuropathology Laboratory, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.

Funding

  • Science and Engineering Research Board
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Department of Science and Technology, Ministry of Science and Technology, India
  • SERB
  • DBT
  • National Science Chair
  • ICMR fellowship
  • DBT fellowship

Cite

APA

Malik, N., Kundu, A., Gupta, Y., Irshad, K., Arora, M., Goswami, S., Mahajan, S., Sarkar, C., Suri, V., Suri, A., Chattopadhyay, P., Sinha, S., & Chosdol, K. (2023). Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221‐3p/222‐3p axis in glioblastoma. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23617

Vancouver

Malik N, Kundu A, Gupta Y, Irshad K, Arora M, Goswami S, et al. Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221‐3p/222‐3p axis in glioblastoma. Molecular Carcinogenesis. 2023. doi:10.1002/mc.23617

BibTeX
@article{Malik2023,
  author = {Malik, Nargis and Kundu, Archismita and Gupta, Yakhlesh and Irshad, Khushboo and Arora, Manvi and Goswami, Sanjeev and Mahajan, Swati and Sarkar, Chitra and Suri, Vaishali and Suri, Ashish and Chattopadhyay, Parthaprasad and Sinha, Subrata and Chosdol, Kunzang},
  title = {Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221‐3p/222‐3p axis in glioblastoma},
  journal = {Molecular Carcinogenesis},
  year = {2023},
  doi = {10.1002/mc.23617}
}
Start for free →